Ensure Access to Biomarker Testing.
HB 567 requires North Carolina insurers to cover biomarker testing to enable personalized cancer and disease treatment decisions.
HB 567 requires North Carolina insurers to cover biomarker testing to enable personalized cancer and disease treatment decisions.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Bill text & amendments
The official bill text and any amendments will be posted here once available.